Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CNC's Health Net unit secures a 54-month Medi-Cal dental contract, which, in turn, is likely to boost its Medicaid membership and presence across California.
CNC's Meridian unit collaborates with Mae to improve health outcomes and address health disparities in Michigan.
Centene forecast third-quarter profit below Wall Street estimates on Tuesday.
Centene stock (NYSE: CNC) currently trades at $73 per share, roughly 25% below its pre-inflation peak level of $97 seen in August 2022, faring much worse than its peer – Molina Healthcare stock (NYSE: MOH) – which has largely traded sideways over this period. The recent fall in CNC stock can be attributed to its updated estimate of 13 million Medicaid members by the end of this year, versus its prior estimate of 13.6 million members.
CNC's unit, Iowa Total Care, wins a new contract to provide Medicaid managed care services, enhancing its presence in Iowa and bringing improved health outcomes in the state.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Shares of health insurers lost ground Wednesday as executives at Centene (CNC) warned about a pullback in the number of people receiving Medicaid benefits.
Shares of major players in the Medicaid business dropped sharply Wednesday after Centene Corp. executives spoke about ongoing tumult in the joint federal and state program.
CNC gains from improved premiums and service revenues, acquisitions and adequate operating cash flows.
The relocation of the facility is expected to enhance CNC's specialty pharmacy capabilities and patient care services.
Centene Corporation is a financially healthy company but is assessed a Hold opportunity for retail value investors due to political uncertainties about government healthcare programs and lack of a dividend. Despite a positive Q2 '24 earnings report, Centene stock has exhibited high volatility and faces growth challenges. Risks for investors include reliance on government programs, potential regulatory changes, and limited growth opportunities in the healthcare sector.